Investigation of the bioequivalence of montelukast chewable tablets after a single oral administration using a validated LC-MS/MS method

References

• LabelleMBelleyMGareauYGauthierJYGuayDGordonRDiscovery of MK-0476, a potent and orally active leukotriene D4 receptor antagonist devoid of peroxisomal enzyme inductionBioorg Med Chem Lett199553283288
   Web of Science ®Google Scholar
• De LepeleireIReissTFRochetteFMontelukast causes prolonged, potent leukotriene D4-receptor antagonism in the airways of patients with asthmaClin Pharmacol Ther199761183929024176
   PubMed Web of Science ®Google Scholar
• ScaparrottaADi PilloSAttanasiMMontelukast versus inhaled corticosteroids in the management of pediatric mild persistent asthmaMultidiscip Respir Med2012711322958412
   PubMedGoogle Scholar
• BlakeKVMontelukast: data from clinical trials in the management of asthmaAnn Pharmacother199933121299131410630831
   PubMed Web of Science ®Google Scholar
• BozekAWarkocka-SzoltysekBFilipowska-GronskaAJarzabJMon-telukast as an add-on therapy to inhaled corticosteroids in the treatment of severe asthma in elderly patientsJ Asthma201249553053422551116
   PubMed Web of Science ®Google Scholar
• DucharmeFMNoyaFJAllen-RameyFCMaieseEMGingrasJBlaisLClinical effectiveness of inhaled corticosteroids versus mon-telukast in children with asthma: prescription patterns and patient adherence as key factorsCurr Med Res Opin201228111111922077107
   PubMed Web of Science ®Google Scholar
• KeithPKKochCDjandjiMMontelukast as add-on therapy with inhaled corticosteroids alone or inhaled corticosteroids and long-acting beta-2-agonists in the management of patients diagnosed with asthma and concurrent allergic rhinitis (the RADAR trial)Can Respir J200916suppl A17A31A
   PubMedGoogle Scholar
• MerckPrescribing Information Singulair®;2013 Available from: http://www.merck.com/product/usa/pi_circulars/s/singulair/singulair_pi.pdf
   Google Scholar
• CingiCGunhanKGage-WhiteLUnluHEfficacy of leukotriene antagonists as concomitant therapy in allergic rhinitisLaryngoscope201012091718172320717951
   PubMed Web of Science ®Google Scholar
• ModgillVBadyalDKVergheseAEfficacy and safety of montelukast add-on therapy in allergic rhinitisMethods Find Exp Clin Pharmacol201032966967421225018
   PubMedGoogle Scholar
• YamamotoHYamadaTSakashitaMEfficacy of prophylactic treatment with montelukast and montelukast plus add-on loratadine for seasonal allergic rhinitisAllergy Asthma Proc2012332e17e2222525385
   PubMed Web of Science ®Google Scholar
• Physician Disc reference; PDR Network, LLC2015 Available from: http://www.pdrhealth.com/drugs/singulairAccessed: July 2015
   Google Scholar
• US Food Drug AdministrationFDA Approves First Generic Versions of Singulair to Treat Asthma, Allergies2012 Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm314436.htm
   Google Scholar
• Sandoz: SPCMontelukast Sodium 4 mg Oral Granules2013 Available from: http://www.medicines.org.uk/emc/medicine/27591
   Google Scholar
• ChengHLeffJAAminRPharmacokinetics, bioavailability, and safety of montelukast sodium (MK-0476) in healthy males and femalesPharm Res19961334454488692739
   PubMed Web of Science ®Google Scholar
• International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH)Stability Testing of New Drug Substances and Products: Q1A(R2). ICH Harmonised Tripartite Guideline. Current Step 4 VersionGenevaICH2003 Available from: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q1A_R2/Step4/Q1A_R2_Guideline.pdfAccessed December 17, 2012
   Google Scholar
• ZaidANAbu GhoshAOSweilehWMAl-JabiSWJaradatNAChewable tablets: is this dosage form well evaluated by Palestinian health professionals?Islam Univ J (Series of Natural Studies and Engineering)20071528394
   Google Scholar
• World Medical Association“Declaration of Helsinki” as Amended by the 59th World Medical AssemblySeoul, South KoreaWorld Medical Association, Inc2008
   Google Scholar
• European Medicines AgencyNote for Guidance on Good Clinical Practice (CPMP/ICH/135/95)London, UKEuropean Medicines Agency1997
   Google Scholar
• International Conference of Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human UseICH Harmonization Tripartite Guideline Guidelines for Good Clinical PracticeGeneva, SwitzerlandICH1996
   Google Scholar
• Food and Drug AdministrationGuidance for Industry: Statistical Approaches to Establishing Bioequivalence2001 Available from: http://www.accessdata.fda.gov/scripts/cder/dissolution/dsp_SearchRe-sults_Dissolutions.cfm?PrintAll=1
   Google Scholar
• Guidance for Industry Exposure-Response Relationships – Study Design, Data Analysis, and Regulatory Applications Available from: http://www.fda.gov/downloads/drugs/guidancecomplianceregulatory-information/guidances/ucm072109.pdf
   Google Scholar
• Guideline on the role of pharmacokinetics in the development of medicinal products in the paediatric population Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003066.pdf
   Google Scholar
• KanjanawartSGaysonsiriDTangsucharitPComparative bioavailability of two montelukast tablet formulations after single-dose administration in healthy Thai male volunteersInt J Clin Pharmacol Ther20114952553021781653
   PubMed Web of Science ®Google Scholar
• ZhengRKimBHPharmacokinetics and bioequivalence of montelukast granules and montelukast tablets in Korean healthy volunteersInt J Clin Pharmacol Ther20145253053624786017
   PubMed Web of Science ®Google Scholar
• DamleBDuczynskiGJeffersBWCrownoverPCoupeALaBadieRRPharmacokinetics of a novel orodispersible tablet of montelukast in healthy subjectsClin Ther20143623624424447534
   PubMed Web of Science ®Google Scholar
• MuñozEOcampoDHEspinalEEYépesNBioequivalence study of two 10 mg montelukast immediate-release tablets formulations: a randomized, single-dose, open-label, two periods, crossover studyJ Bioequivalence Bioavailability2014638690
   Google Scholar
• AbbasMKhanAMAminSRiffatSAshrafMWaheedNBioequivalence study of montelukast tablets in healthy Pakistani volunteersPak J Pharm Sci201326225525923455193
   PubMed Web of Science ®Google Scholar
• EzzeldinEAbo-TalibNFTammamMHShahatAADevelopment and validation of LC/MS/MS method for the simultaneous determination of montelukast, gliclazide, and nifedipine and its application to a pharmacokinetic studyBiomed Chromatogr20142881048105624424850
   PubMed Web of Science ®Google Scholar
• MuppavarapuRGuttikarSRajappanMKamarajanKMullangiRSensitive LC-MS/MS-ESI method for simultaneous determination of montelukast and fexofenadine in human plasma: application to a bioequivalence studyBiomed Chromatogr20142881048105624424850
   PubMed Web of Science ®Google Scholar
• European Medicines AgencyNote for Guidance on the Investigation of Bioavailability and Bioequivalence (CPMP/EWP/QWP/1401/98)London, UKEuropean Medicines Agency2001
   Google Scholar
• Food and Drug AdministrationGlossary of Terms2012 Available from: http://www.fda.gov/drugs/informationondrugs/ucm079436.htm
   Google Scholar